• Be A Partner
  • Social Responsibility
    • Students Training
  • IR
    • Investor Relations
    • Financial Charts
    • Annual Reports
  • News
    • PRESS RELEASES
    • SOCIAL EVENTS
    • CONFERENCES
  • Careers
  • Covid-19
  • Report a side effect
  • Contact Us
    • Branches
  • Home
  • We are Eipico
    We are Eipico
    EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million.
    • Uniqueness
      • WHO Approval
      • Sterile products Area
      • Automatic Ampoules Inspection
      • Eipico Ophthalmology
      • Primary packaging materials
      • Restricted-access barrier system
      • Distribution Channel
    • Our History
    • Vision, Mission & Values
    • Chairman Message
    • Eipico Employees
    • Manufacturing Facilities
    • Media Library
  • Global
    Global
    EIPICO is ranked Number 1 in Egyptian Exports of Pharmaceutical Products, capturing 29% of Egypt’s Total Exports of Pharmaceutical Products, by Value.
    • Eipico Destination
  • Manufacturing Facilities
    Manufacturing Facilities
    EIPICO is the Leading Egyptian Pharmaceutical Company, in Production, by Units. It is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market.
    • Factory 1
    • Factory 2
    • Factory 3 (Biotechnology)
    • Eiaco Factory
    • Batterjee Factory
    • EIPICO Plastic Factory
  • R&D And Quality
    R&D And Quality
    EIPICO provides High Quality Pharmaceutical Products at reasonable prices, thus assisting human healthcare improvement .
    • Quality Assurance
    • Quality Control
    • R&D
    • Regulatory Affairs
    • Global Accreditation
    • Track and Trace
  • Products
  • Biotechnology
WHO Approval
You are here : >>Who We Are >>Uniqueness >>WHO Approval
WHO Site Compliance Certificate
After the conduction of the external audit by the Prequalification Inspection Team from the World Health Organization (WHO), the Prequalification Inspection Group has recommended that EIPICO site is considered to be compliant with the standards of Good Manufacturing Practices (GMP) published by the World Health Organization (WHO) for the scope activities listed below:
► Manufacture and packaging of aseptically filled powder for solution for injection in the Cephalosporin Block.
Reference
https://extranet.who.int/pqweb/news/who-prequalifies-first-products-manufactured-egypt



 Find out more  


STERILE PRODUCTS AREA

Are areas that have HEPA filtration to remove particles from the air. They are used for manufacturing where high levels of cleanliness and sterility are required.

Read more




AUTOMATIC AMPOULES INSPECTION

Inspection of cracks on the glass vials and ampoules and other defects such as scratches, bubbles, black spots and other defects that can cause contamination of the contents or a breach of sterility.

Read more




EIPICO OPHTHALMOLOGY 

EIPICO is ranked Number 1 in the Egyptian Ophthalmic Market, by Units.

Read more






WE ARE EIPICO

  • Uniqueness
  • Our History
  • Vision, Mission & Values
  • Chairman Message
  • Eipico Employees

Manufacturing Facilities

  • Factory 1
  • Factory 2
  • Factory 3
  • Eiaco Factory
  • Batterjee Factory
  • Plastic Factory

Products

  • Eipico Product
  • Eipico Products By Alphabet

Contact Us

EIPICO, Tenth of Ramadan City - 1st Industrial Zone B1, Egypt.

Telephone : +20554499199
Fax : +20554499306

eipico@eipico.com.eg

Back to top
Powered by EIPICO Team
    Visitors Count : 1116975